Novel Compositions for Treating or Preventing Dermal Disorders

Summary

This trial examines the impact of a topical formulation of rapamycin on dermal thickness and senescence.

Timeline

Start

2017-09-25

Primary completion

2017-11-30

Completion

2017-11-30

Publications

• Chung CL, Lawrence I, Hoffman M, Elgindi D, Nadhan K, Potnis M, Jin A, Sershon C, Binnebose R, Lorenzini A, Sell C. Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial. Geroscience. 2019 Dec;41(6):861-869. doi: 10.1007/s11357-019-00113-y. Epub 2019 Nov 25.

Drugs

Indications